Skip to content
  • Home
  • About
  • Contact
  • Services
  • Advertise with Us
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A
How Poor Clinical Trial Recruitment Is Quietly Killing Drug Development
Posted in
  • Industry Landscape

How Poor Clinical Trial Recruitment Is Quietly Killing Drug Development

In 2024, nearly 85 percent of U.S. clinical trials failed to enroll sufficient participants on schedule, … How Poor Clinical Trial Recruitment Is Quietly Killing Drug DevelopmentRead more

by Jayshree Gondane•February 3, 2026February 3, 2026•0
Why So Many Pharma Companies Get Stuck in Phase I Clinical Trials
Posted in
  • Regulatory Compliance

Why So Many Pharma Companies Get Stuck in Phase I Clinical Trials

In the United States, drug development rarely collapses at the finish line. It slows, fragments, and … Why So Many Pharma Companies Get Stuck in Phase I Clinical TrialsRead more

by Jayshree Gondane•February 3, 2026February 3, 2026•0
Designing Content Ecosystems for Specialty Brands
Posted in
  • Case Studies & Trends
  • Digital Transformation
  • Strategy & Execution

Designing Content Ecosystems for Specialty Brands

In today’s competitive pharmaceutical landscape, specialty brands face unique challenges in reaching and engaging healthcare professionals … Designing Content Ecosystems for Specialty BrandsRead more

by Jayshree Gondane•February 2, 2026February 2, 2026•0
Patient Education Pipelines Built With Automation
Posted in
  • Digital Transformation
  • Strategy & Execution

Patient Education Pipelines Built With Automation

Patient education is a cornerstone of modern healthcare, impacting treatment adherence, clinical outcomes, and patient satisfaction. … Patient Education Pipelines Built With AutomationRead more

by Jayshree Gondane•February 2, 2026February 2, 2026•0
Identifying Hidden HCP Segments With Predictive AI hidden HCP segments
Posted in
  • Industry Landscape
  • Strategy & Execution

Identifying Hidden HCP Segments With Predictive AI hidden HCP segments

In the increasingly competitive pharmaceutical landscape, reaching the right healthcare providers is no longer a matter … Identifying Hidden HCP Segments With Predictive AI hidden HCP segmentsRead more

by Jayshree Gondane•February 2, 2026February 2, 2026•0
Optimizing Outreach for Nurse Practitioners and Physician
Posted in
  • Strategy & Execution

Optimizing Outreach for Nurse Practitioners and Physician

In the United States today, nurse practitioners (NPs) and physician assistants (PAs) are no longer peripheral … Optimizing Outreach for Nurse Practitioners and PhysicianRead more

by Jayshree Gondane•February 2, 2026February 2, 2026•0
AI-Based Content Scoring for Medical Accuracy: Ensuring Reliable Communication in U.S. Pharma
Posted in
  • Regulatory Compliance

AI-Based Content Scoring for Medical Accuracy: Ensuring Reliable Communication in U.S. Pharma

Maintaining medical accuracy in pharmaceutical content is critical for both regulatory compliance and physician trust. With … AI-Based Content Scoring for Medical Accuracy: Ensuring Reliable Communication in U.S. PharmaRead more

by Jayshree Gondane•February 1, 2026February 1, 2026•0
Digital Storytelling Frameworks for Complex Therapies
Posted in
  • Strategy & Execution

Digital Storytelling Frameworks for Complex Therapies

The rise of complex therapies-ranging from gene and cell therapies to advanced biologics-has transformed the U.S. … Digital Storytelling Frameworks for Complex TherapiesRead more

by Jayshree Gondane•February 1, 2026February 1, 2026•0
Rep Satisfaction Tracking Using Sentiment
Posted in
  • Strategy & Execution

Rep Satisfaction Tracking Using Sentiment

In the highly competitive U.S. pharmaceutical market, commercial performance is increasingly defined not just by product … Rep Satisfaction Tracking Using SentimentRead more

by Jayshree Gondane•February 1, 2026February 1, 2026•0
Building Digital Communities Around High-Priority Therapies
Posted in
  • Digital Transformation
  • Industry Landscape
  • Strategy & Execution

Building Digital Communities Around High-Priority Therapies

Digital engagement now shapes how healthcare stakeholders learn, interact, and make decisions in the United States. … Building Digital Communities Around High-Priority TherapiesRead more

by Jayshree Gondane•January 31, 2026January 31, 2026•0

Posts pagination

Previous 1 … 25 26 27 … 61 Next

Recent Posts

  • Understanding Prior Authorization in Pharmaceutical Sales
  • Side Hustles for Pharmaceutical Sales Representatives
  • How to Handle Burnout in Pharmaceutical Sales
  • Work-Life Balance Tips for Pharmaceutical Sales Reps
  • Continuing Education Options for Pharma Professionals

Recent Comments

No comments to show.
Copyright © 2026 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A